A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
- PMID: 20195903
- PMCID: PMC2950079
- DOI: 10.1007/s10545-010-9061-2
A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
Abstract
Over the years, the mitochondrial fatty acid β-oxidation (FAO) pathway has been characterised at the biochemical level as well as the molecular biological level. FAO plays a pivotal role in energy homoeostasis, but it competes with glucose as the primary oxidative substrate. The mechanisms behind this so-called glucose-fatty acid cycle operate at the hormonal, transcriptional and biochemical levels. Inherited defects for most of the FAO enzymes have been identified and characterised and are currently included in neonatal screening programmes. Symptoms range from hypoketotic hypoglycaemia to skeletal and cardiac myopathies. The pathophysiology of these diseases is still not completely understood, hampering optimal treatment. Studies of patients and mouse models will contribute to our understanding of the pathogenesis and will ultimately lead to better treatment.
Figures

Similar articles
-
Pathophysiology of fatty acid oxidation disorders.J Inherit Metab Dis. 2010 Oct;33(5):533-7. doi: 10.1007/s10545-010-9170-y. Epub 2009 Oct 10. J Inherit Metab Dis. 2010. PMID: 20824345 Review.
-
Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.J Inherit Metab Dis. 2010 Oct;33(5):539-46. doi: 10.1007/s10545-010-9121-7. Epub 2010 Jun 8. J Inherit Metab Dis. 2010. PMID: 20532823 Free PMC article. Review.
-
Update on mitochondrial fatty acid oxidation disorders.J Inherit Metab Dis. 2010 Oct;33(5):467-8. doi: 10.1007/s10545-010-9208-1. J Inherit Metab Dis. 2010. PMID: 20842433 No abstract available.
-
Disease mechanisms and protein structures in fatty acid oxidation defects.J Inherit Metab Dis. 2010 Oct;33(5):547-53. doi: 10.1007/s10545-010-9046-1. Epub 2010 Feb 12. J Inherit Metab Dis. 2010. PMID: 20151199
-
The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.J Inherit Metab Dis. 2010 Oct;33(5):479-94. doi: 10.1007/s10545-010-9104-8. Epub 2010 May 20. J Inherit Metab Dis. 2010. PMID: 20490924 Free PMC article.
Cited by
-
Sulforaphane Protects against Unilateral Ureteral Obstruction-Induced Renal Damage in Rats by Alleviating Mitochondrial and Lipid Metabolism Impairment.Antioxidants (Basel). 2022 Sep 20;11(10):1854. doi: 10.3390/antiox11101854. Antioxidants (Basel). 2022. PMID: 36290577 Free PMC article.
-
Potential Role of L-Carnitine in Autism Spectrum Disorder.J Clin Med. 2021 Mar 13;10(6):1202. doi: 10.3390/jcm10061202. J Clin Med. 2021. PMID: 33805796 Free PMC article. Review.
-
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies.Front Neurol. 2020 Jun 23;11:514. doi: 10.3389/fneur.2020.00514. eCollection 2020. Front Neurol. 2020. PMID: 32655480 Free PMC article.
-
Changes Induced by Aging and Long-Term Exercise and/or DHA Supplementation in Muscle of Obese Female Mice.Nutrients. 2022 Oct 12;14(20):4240. doi: 10.3390/nu14204240. Nutrients. 2022. PMID: 36296923 Free PMC article.
-
Potential Lipid Signatures for Diagnosis and Prognosis of Sepsis and Systemic Inflammatory Response Syndrome.Metabolites. 2020 Sep 1;10(9):359. doi: 10.3390/metabo10090359. Metabolites. 2020. PMID: 32882869 Free PMC article.
References
-
- Binas B, Han XX, Erol E, et al. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am J Physiol Endocrinol Metab. 2003;285:E481–E489. - PubMed
-
- Bonnet D, Martin D, de Lonlay P, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100:2248–2253. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical